2014 - Page 296 of 491 - 24/7 Wall St.

247sarah | May 27, 2014 at 3:03 PM EDT

U.S. Services Sector Soars in May

ThinkStockThe Markit Flash U.S. Services Purchasing Managers’ Index (PMI) jumped 6.2% to 58.4 for May, according to a Markit report…

Jon C. Ogg | May 27, 2014 at 2:59 PM EDT

Tesla Scores Junk Bond Rating from S&P

Courtesy of Tesla MotorsTesla Motors, Inc. (NASDAQ: TSLA) is not exactly the sort of company you think of with a…

Jon C. Ogg | May 27, 2014 at 2:21 PM EDT

Citi Sees Decline in Trading, No Clear Mass Exit for Citi Holdings

Wikimedia CommonsCitigroup Inc. (C) shares may still be up on the day, but shares have handily pulled back from their…

247sarah | May 27, 2014 at 1:57 PM EDT

American Science and Engineering Books a Banner Year

ThinkStockSince reporting Q4 and full-year fiscal 2014 earnings Thursday night, shares of X-ray bomb detector company American Science & Engineering (NASDAQ:…

Jon C. Ogg | May 27, 2014 at 1:35 PM EDT

Pfizer’s Real Issue: Identity Crisis Against Peers

Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance…

247sarah | May 27, 2014 at 1:24 PM EDT

Networks Look to Dramas to Draw the Viewers Advertisers Crave

foxWith the 2013-2014 season in the books, executives are turning towards what they hope will be a promising fall slate.…

Jon C. Ogg | May 27, 2014 at 1:10 PM EDT

Is Spherix For Real?

Spherix was not just moving higher on Tuesday. Its shares soared, and the stock was even the single best performer…

247sarah | May 27, 2014 at 12:49 PM EDT

Can NBC’s New Medical Drama ‘The Night Shift’ Channel the Success of ‘E.R.’?

NBCHospital dramas are a dime a dozen, but when done right they can become an iconic piece of TV history,…

Paul Ausick | May 27, 2014 at 12:05 PM EDT

Ford’s 2015 Mustang Takes Europe by Storm

Last Saturday was the first day that European drivers could place their orders for the all-new Mustang. Ford even offers…

Jon C. Ogg | May 27, 2014 at 11:55 AM EDT

Would Mark Zuckerberg Appear in Court in Iran?

ThinkstockSometimes strange things happen in local court cases against large multinational companies that are based in the United States and…

Thomas Frohlich | May 27, 2014 at 11:27 AM EDT

Nine Companies With the Most Unusual Origins

Wikimedia CommonsSome of America’s most well-known companies went through big changes before becoming the dominant corporations they are today. The origin of…

Paul Ausick | May 27, 2014 at 11:25 AM EDT

Why Apple Posted 52-Week High

When Apple shares put in a new high, most of us want to know what's going on with the world's…

Jon C. Ogg | May 27, 2014 at 11:15 AM EDT

Credit Suisse Defends Mortgage REITs

ThinkstockMortgage real estate investment trusts (REITs) are being defended by Doug Harter, the analyst who follows this sector for Credit…

Trey Thoelcke | May 27, 2014 at 11:00 AM EDT

Merrill Lynch Survey Shows Homebuilding Picking Back Up

Merrill Lynch analysts surveyed and spoke to around 90 community managers for the top homebuilders across the country to gauge…

Paul Ausick | May 27, 2014 at 10:50 AM EDT

BioCryst Crushes It on Rare Immune Disorder Drug Trial

BioCryst Pharmaceuticals broke higher Tuesday morning, following the company's announcement that its oral drug for hereditary angioedema met objectives established…

1 … 294 295 296 297 298 … 491

Year: 2014

U.S. Services Sector Soars in May

Tesla Scores Junk Bond Rating from S&P

Citi Sees Decline in Trading, No Clear Mass Exit for Citi Holdings

American Science and Engineering Books a Banner Year

Pfizer’s Real Issue: Identity Crisis Against Peers

Networks Look to Dramas to Draw the Viewers Advertisers Crave

Is Spherix For Real?

Can NBC’s New Medical Drama ‘The Night Shift’ Channel the Success of ‘E.R.’?

Ford’s 2015 Mustang Takes Europe by Storm

Would Mark Zuckerberg Appear in Court in Iran?

Nine Companies With the Most Unusual Origins

Why Apple Posted 52-Week High

Credit Suisse Defends Mortgage REITs

Merrill Lynch Survey Shows Homebuilding Picking Back Up

BioCryst Crushes It on Rare Immune Disorder Drug Trial

A $1.4 Million 401(k) Balance Can Still Cost You Thousands in Taxes Without This One Move

UGL vs. GLL: The Leveraged Gold Trade for Every Market Direction

A $500,000 401(k) Balance Can Lose $140,000 to Hidden Fees. Here’s What to Do Now

A $1.4 Million 401(k) Balance Can Still Cost You Thousands in Taxes Without This One Move

A $500,000 401(k) Balance Can Lose $140,000 to Hidden Fees. Here's What to Do Now

A $1.4 Million 401(k) Balance Can Still Cost You Thousands in Taxes Without This One Move

UGL vs. GLL: The Leveraged Gold Trade for Every Market Direction

U.S. Services Sector Soars in May

Tesla Scores Junk Bond Rating from S&P

Citi Sees Decline in Trading, No Clear Mass Exit for Citi Holdings

American Science and Engineering Books a Banner Year

Pfizer’s Real Issue: Identity Crisis Against Peers

Networks Look to Dramas to Draw the Viewers Advertisers Crave

Is Spherix For Real?

Can NBC’s New Medical Drama ‘The Night Shift’ Channel the Success of ‘E.R.’?

Ford’s 2015 Mustang Takes Europe by Storm

Would Mark Zuckerberg Appear in Court in Iran?

Nine Companies With the Most Unusual Origins

Why Apple Posted 52-Week High

Credit Suisse Defends Mortgage REITs

Merrill Lynch Survey Shows Homebuilding Picking Back Up

BioCryst Crushes It on Rare Immune Disorder Drug Trial

A $1.4 Million 401(k) Balance Can Still Cost You Thousands in Taxes Without This One Move

UGL vs. GLL: The Leveraged Gold Trade for Every Market Direction

A $500,000 401(k) Balance Can Lose $140,000 to Hidden Fees. Here’s What to Do Now

Featured Reads

A $1.4 Million 401(k) Balance Can Still Cost You Thousands in Taxes Without This One Move

A $500,000 401(k) Balance Can Lose $140,000 to Hidden Fees. Here's What to Do Now